Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MALDI imaging mass spectrometry--painting molecular pictures.

ABSTRACT: MALDI Imaging Mass Spectrometry is a molecular analytical technology capable of simultaneously measuring multiple analytes directly from intact tissue sections. Histological features within the sample can be correlated with molecular species without the need for target-specific reagents such as antibodies. Several studies have demonstrated the strength of the technology for uncovering new markers that correlate with disease severity as well as prognosis and therapeutic response. This review describes technological aspects of imaging mass spectrometry together with applications in cancer research.

SUBMITTER: Schwamborn K

PROVIDER: S-EPMC2981679 | biostudies-other | 2010 Dec

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Rapid MALDI mass spectrometry imaging for surgical pathology.

Project description: Not available

| S-EPMC6609678 | biostudies-other

Molecular morphology of the chick heart visualized by MALDI imaging mass spectrometry.

Project description: Not available

| S-EPMC3089908 | biostudies-literature

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging

Project description:Retinoblastoma (RB) is an intraocular childhood tumor which, if left untreated, leads to blindness and mortality. Nucleolin (NCL) protein which is differentially expressed on the tumor cell surface, binds ligands and regulates carcinogenesis and angiogenesis. We found that NCL is over expressed in RB tumor tissues and cell lines compared to normal retina. We studied the effect of nucleolin-aptamer (NCL-APT) to reduce proliferation in RB tumor cells. Aptamer treatment on the RB cell lines (Y79 and WERI-Rb1) led to significant inhibition of cell proliferation. Locked nucleic acid (LNA) modified NCL-APT administered subcutaneously (s.c.) near tumor or intraperitoneally (i.p.) in Y79 xenografted nude mice resulted in 26 and 65% of tumor growth inhibition, respectively. Downregulation of inhibitor of apoptosis proteins, tumor miRNA-18a, altered serum cytokines, and serum miRNA-18a levels were observed upon NCL-APT treatment. Desorption electrospray ionization mass spectrometry (DESI MS)-based imaging of cell lines and tumor tissues revealed changes in phosphatidylcholines levels upon treatment. Thus, our study provides proof of concept illustrating NCL-APT-based targeted therapeutic strategy and use of DESI MS-based lipid imaging in monitoring therapeutic responses in RB.

2016-11-15 | GSE89818 | GEO

Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging.

Project description: Not available

| S-EPMC3790202 | biostudies-literature

MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology.

Project description: Not available

| S-EPMC2522327 | biostudies-other

Molecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry.

Project description: Not available

| S-EPMC5030664 | biostudies-literature

Stretched tissue mounting for MALDI mass spectrometry imaging.

Project description: Not available